Industry News

Aerie Signs License Agreement With Santen for Rhopressa and Rocklatan in Europe and Several Other Regions

Santen and Aerie Pharmaceuticals have announced an exclusive development and commercialization partnership for Rhopressa/Rhokiinsa (netarsudil ophthalmic solution) 0.02% and Rocklatan/Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%.

Aerie Signs License Agreement With Santen for Rhopressa and Rocklatan in Europe and Several Other Regions
December 08, 2021
Envision Acquires National Virtual Program To Help Students Who are Blind or Visually Impaired

Envision will help students who are blind or visually impaired to enter college and workforce with the acquisition of the College Success Program (CSP).

Envision Acquires National Virtual Program To Help Students Who are Blind or Visually Impaired
December 07, 2021
Alimera Sciences Welcomes Ophthalmic Strategic Consultant Erin Parsons to Its Board of Directors

Erin Parsons has been appointed to Alimera Sciences' Board of Directors. Ms. Parsons has more than 20 years of experience in the ophthalmology sector.

Alimera Sciences Welcomes Ophthalmic Strategic Consultant Erin Parsons to Its Board of Directors
December 06, 2021
LayerBio Granted U.S. Patent for OcuRing Drug Delivery Platform

LayerBio announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 11,185,441 for its OcuRing Drug Delivery Platform.

LayerBio Granted U.S. Patent for OcuRing Drug Delivery Platform
December 02, 2021
Visus Announces Positive Topline Clinical Data from Phase 2 VIVID Study of BRIMOCHOL for Treatment of Presbyopia

Visus Therapeutics has revealed positive topline results from VIVID, the company’s Phase 2 study of three novel topical ophthalmic formulations under investigation for the treatment of presbyopia.

Visus Announces Positive Topline Clinical Data from Phase 2 VIVID Study of BRIMOCHOL for Treatment of Presbyopia
December 01, 2021
Notal Vision Monitoring Center Reports AI Analysis of 10 Million ForeseeHome AMD Home Monitoring Tests

The Notal Vision Monitoring Center is celebrating the ten millionth test completed by over 20,000 patients using the FDA-cleared ForeseeHome gadget, which was analyzed through artificial intelligence (AI).

Notal Vision Monitoring Center Reports AI Analysis of 10 Million ForeseeHome AMD Home Monitoring Tests
December 01, 2021
Kubota Vision Unveils Study Data for Wearable Myopia-Control Device

Kubota Vision announced the publication of a new paper in the journal Scientific Reports: “Effect of short-term peripheral myopic defocus on ocular biometrics using Fresnel “press-on” lenses in humans”.

Kubota Vision Unveils Study Data for Wearable Myopia-Control Device
November 30, 2021
VSY Biotechnology GmbH Discovers How to Connect the Golden Ratio Concept to its New Intraocular Lens Technology

Inspired by the Golden Ratio, VSY Biotechnology GmbH with its trifocal technology has created an intraocular lens that has virtually the same conditions as the natural refraction of light waves in the human eye.

VSY Biotechnology GmbH Discovers How to Connect the Golden Ratio Concept to its New Intraocular Lens Technology
November 30, 2021
Dutch Evmann is Looking for a Substantial Investment Opportunity in the United States

Dutch Evmann Investments Holding BV, which produces and sells high-quality, innovative products in the field of Ophthalmology and Orthopedics is searching for a substantial investment opportunity in the United States.

Dutch Evmann is Looking for a Substantial Investment Opportunity in the United States
November 25, 2021
Hilco Vision Acquires Simovision BV, Distributor of Ophthalmic Products

Hilco Vision announced the acquisition of Belgium and Netherlands-based Simovision BV as of November 17, 2021.

Hilco Vision Acquires Simovision BV, Distributor of Ophthalmic Products
November 24, 2021
Daha fazla